Dogwood Therapeutics, Inc.
General ticker "DWTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.5M (TTM average)
Dogwood Therapeutics, Inc. follows the US Stock Market performance with the rate: 6.3%.
Estimated limits based on current volatility of 4.1%: low 6.25$, high 6.78$
Factors to consider:
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.71$, 25.50$]
- 2024-12-30 to 2025-12-30 estimated range: [4.81$, 17.60$]
Financial Metrics affecting the DWTX estimates:
- Negative: with PPE of -2.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -43.58 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: Shareholder equity ratio, % of 91.39 > 63.39
- Positive: Investing cash flow per share per price, % of 0 > -0.66
Short-term DWTX quotes
Long-term DWTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $15.64MM | $12.32MM | $5.45MM |
| Operating Income | $-15.64MM | $-12.32MM | $-5.45MM |
| Non-Operating Income | $-0.32MM | $0.07MM | $0.15MM |
| R&D Expense | $10.80MM | $8.07MM | $1.73MM |
| Income(Loss) | $-15.96MM | $-12.25MM | $-5.30MM |
| Profit(Loss)* | $-15.96MM | $-12.25MM | $-5.30MM |
| Stockholders Equity | $14.50MM | $7.33MM | $3.81MM |
| Assets | $15.78MM | $8.37MM | $4.17MM |
| Operating Cash Flow | $-15.69MM | $-11.47MM | $-4.87MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $-0.10MM | $4.49MM | $1.16MM |
| Earnings Per Share** | $-47.90 | $-27.66 | $-7.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.